Brain "fog," inflammation a nd obesity: Key aspects of neuropsychiatric disorders improved by luteolin

Frontiers in Neuroscience

Volumn 9, Issue JUN, 2015, Pages

  Theoharides, Theoharis C ^a   Stewart, Julia M ^a   Hatziagelaki, Erifili ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

Brain; Cognition; Cytokines; Fog; Histamine hydroxytyrosol; Inflammation; Luteolin; Mast cells; Obesity; Olive fruit extract

Indexed keywords

CURCUMIN; FLAVONE DERIVATIVE; FLAVONOID; HISTAMINE; LUTEOLIN; OLIVE EXTRACT; PLANT EXTRACT; RESVERATROL; TETRAMETHOXYLUTEOLIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENTION DISTURBANCE; AUTISM; BRAIN FOG; COGNITIVE DEFECT; DISORDERS OF HIGHER CEREBRAL FUNCTION; DRUG MECHANISM; HEALTH CARE COST; HUMAN; MAST CELL; MASTOCYTOSIS; MEMORY DISORDER; MENTAL DISEASE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OBESITY; OLIVE; PATHOGENESIS;

EID: 84935075885     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00225     Document Type: Article

References (224)

1. Abraham, S.N., St John, A.L. (2010). Mast cell-orchestrated immunity to pathogens . Nat. Rev. Immunol 10, 440-452.
2. Aguilar-Valles, A., Inoue, W., Rummel, C.and Luheshi, G.N. (2015). Obesity, adipokines and neuroinflammation. Neuropharmacology in press.
3. Alevizos, M., Karagkouni, A., Panagiotidou, S., Vasiadi, M.and Theoharides, T.C. (2013). Stress triggers coronary mast cells leading to cardiac events. Ann Allergy Asthma Immunol 112, 309-316.
4. Alstadhaug, K.B. (2014). Histamine in migraine and brain. Headache 54, 246-259.
5. Alvarez, E.O., Ruarte, M.B.and Banzan, A.M. (2001). Histaminergic systems of the limbic complex on learning and motivation. Behav. Brain Res. 124, 195-202.
6. Alzheimers Association. 2015 Alzheimer's Disease Facts and Figures. 2015.
7. Ando, C., Takahashi, N., Hirai, S., Nishimura, K., Lin, S., Uemura, T.et al (2009). Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation. FEBS Lett. 583, 3649-3654.
8. Arnoldussen, I.A., Kiliaan, A.J.and Gustafson, D.R. (2014). Obesity and dementia: adipokines interact with the brain. Eur. Neuropsychopharmacol. 24, 1982-1999.
9. Asadi, S., Zhang, B., Weng, Z., Angelidou, A., Kempuraj, D., Alysandratos, K. D.et al (2010). Luteolin and thiosalicylate inhibit HgCl(2) and thimerosal-induced VEGF release from human mast cells. Int J Immunopathol. Pharmacol. 23, 1015-1020.
10. Banuelos-Cabrera, I., Valle-Dorado, M.G., Aldana, B.I., Orozco-Suarez, S.A.and Rocha, L. (2014). Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders. Arch. Med Res. 45, 677-686.
11. Baptista, F.I., Henriques, A.G., Silva, A.M., Wiltfang, J.and da Cruz e Silva OA (2014). Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease. ACS Chem. Neurosci. 83-92.
12. Beumer, W., Gibney, S.M., Drexhage, R.C., Pont-Lezica, L., Doorduin, J., Klein, H.C.et al (2012). The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc. Biol. 92, 959-975.
13. Blank, U., Rivera, J. (2004). The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25, 266-273.
14. Bodmer, S., Imark, C.and Kneubuhl, M. (1999). Biogenic amines in foods: histamine and food processing. Inflamm. Res. 48, 296-300.
15. Boudouda, H.B., Zeghib, A., Karioti, A., Bilia, A.R., Ozturk, M., Aouni, M.et al (2015). Antibacterial, antioxidant, anti-cholinesterase potential and flavonol glycosides of Biscutella raphanifolia (Brassicaceae). Pak. J Pharm. Sci. 28, 153-158.
16. Brewer, J.H., Thrasher, J.D., Straus, D.C., Madison, R.A.and Hooper, D. (2013). Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins.(Basel) 5, 605-617.
17. Brioni, J.D., Esbenshade, T.A., Garrison, T.R., Bitner, S.R.and Cowart, M.D. (2011). Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease. J Pharmacol. Exp. Ther. 336, 38-46.
18. Brown, J.E., Rice-Evans, C.A. (1998). Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro. Free Radic. Res. 29, 247-255.
19. Bryniarski, K., Ptak, W., Jayakumar, A., Pullmann, K., Caplan, M.J., Chairoungdua, A.et al (2013). Antigen7 specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immunol 132, 170-181.
20. Byrne, M.L., O'Brien-Simpson, N.M., Mitchell, S.A.and Allen, N.B. (2015). Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes? Child Psychiatry Hum. Dev. in press.
21. Cao, J., Papadopoulou, N., Kempuraj, D., Boucher, W.S., Sugimoto, K., Cetrulo, C.L.et al (2005). Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 174, 7665-7675.
22. Chakraborty, S., Kaushik, D.K., Gupta, M.and Basu, A. (2010). Inflammasome signaling at the heart of central nervous system pathology. J Neurosci. Res 88, 1615-1631.
23. Chen, H.Q., Jin, Z.Y., Wang, X.J., Xu, X.M., Deng, L.and Zhao, J.W. (2008). Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci. Lett. 448, 175-179.
24. Chen, Z., Zheng, S., Li, L.and Jiang, H. (2014). Metabolism of flavonoids in human: a comprehensive review. Curr Drug Metab 15, 48-61.
25. Chrostowska, M., Szyndler, A., Hoffmann, M.and Narkiewicz, K. (2013). Impact of obesity on cardiovascular health. Best. Pract. Res Clin Endocrinol Metab 27, 147-156.
26. Corbett, A., Smith, J.and Ballard, C. (2012). New and emerging treatments for Alzheimer's disease. Expert. Rev. Neurother. 12, 535-543.
27. Corcoran, M.P., McKay, D.L.and Blumberg, J.B. (2012). Flavonoid basics: chemistry, sources, mechanisms of action, and safety. J Nutr Gerontol. Geriatr. 31, 176-189.
28. Crago, B.R., Gray, M.R., Nelson, L.A., Davis, M., Arnold, L.and Thrasher, J.D. (2003). Psychological, neuropsychological, and electrocortical effects of mixed mold exposure. Arch. Environ. Health 58, 452- 463.
29. da Silveira, C.K., Furini, C.R., Benetti, F., Monteiro, S.C.and Izquierdo, I. (2013). The role of histamine receptors in the consolidation of object recognition memory. Neurobiol. Learn. Mem. 103, 64-71.
30. Deqiu, Z., Kang, L., Jiali, Y., Baolin, L.and Gaolin, L. (2011). Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium. Biochimie 93, 506-512.
31. Dirscherl, K., Karlstetter, M., Ebert, S., Kraus, D., Hlawatsch, J., Walczak, Y.et al (2010). Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J Neuroinflammation. 7, 3.
32. Donelan, J., Boucher, W., Papadopoulou, N., Lytinas, M., Papaliodis, D.and Theoharides, T.C. (2006). Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci USA 103, 7759-7764.
33. Dong, H., Zhang, X.and Qian, Y. (2014). Mast cells and neuroinflammation. Med Sci. Monit. Basic Res. 20, 200-206.
34. Drzezga, A., Becker, J.A., Van Dijk, K.R., Sreenivasan, A., Talukdar, T., Sullivan, C.et al (2011). Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain 134, 1635-1646.
35. Empting, L.D. (2009). Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicol. Ind. Health 25, 577-581.
36. Enoksson, M., Lyberg, K., Moller-Westerberg, C., Fallon, P.G., Nilsson, G.and Lunderius-Andersson, C. (2011). Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 186, 2523-2528.
37. Enseleit, F., Sudano, I., Periat, D., Winnik, S., Wolfrum, M., Flammer, A.J.et al (2012). Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J 33, 1589-1597.
38. Esposito, P., Chandler, N., Kandere-Grzybowska, K., Basu, S., Jacobson, S., Connolly, R.et al (2002). Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 303, 1061-1066.
39. Esposito, P., Gheorghe, D., Kandere, K., Pang, X., Conally, R., Jacobson, S.et al (2001). Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 888, 117-127.
40. Farr, S.A., Price, T.O., Dominguez, L.J., Motisi, A., Saiano, F., Niehoff, M.L.et al (2012). Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers.Dis. 28, 81-92.
41. Fatokun, A.A., Liu, J.O., Dawson, V.L.and Dawson, T.M. (2013). Identification through high-throughput screening of 4'-methoxyflavone and 3', 4'-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos. Br J Pharmacol 169, 1263-1278.
42. Franco, J.L., Posser, T., Missau, F., Pizzolatti, M.G., Dos Santos, A.R., Souza, D. O.et al (2010). Structure activity relationship of flavonoids derived from medicinal plants in preventing methylmercury-induced mitochondrial dysfunction. Environ.Toxicol.Pharmacol 30, 272-278.
43. Fu, X., Zhang, J., Guo, L., Xu, Y., Sun, L., Wang, S.et al (2014). Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats 1. Pharmacol. Biochem. Behav. 126, 122-130.
44. Funakoshi-Tago, M., Okamoto, K., Izumi, R., Tago, K., Yanagisawa, K., Narukawa, Y.et al (2015). Anti8 inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway. Int.Immunopharmacol. 25, 189-198.
45. Galli, S.J., Grimbaldeston, M.and Tsai, M. (2008). Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8, 478-486.
46. Galli, S.J., Tsai, M.and Piliponsky, A.M. (2008). The development of allergic inflammation. Nature 454, 445- 454.
47. Gonzalez-Correa, J.A., Navas, M.D., Lopez-Villodres, J.A., Trujillo, M., Espartero, J.L.and De La Cruz, J.P. (2008). Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neurosci. Lett. 446, 143-146.
48. Gordon, W.A., Cantor, J.B., Johanning, E., Charatz, H.J., Ashman, T.A., Breeze, J.L.et al (2004). Cognitive impairment associated with toxigenic fungal exposure: a replication and extension of previous findings. Appl. Neuropsychol. 11, 65-74.
49. Grosso, C., Valentao, P., Ferreres, F.and Andrade, P.B. (2013). The use of flavonoids in central nervous system disorders. Curr Med Chem 20, 4697-4719.
50. Gupta, S., Ellis, S.E., Ashar, F.N., Moes, A., Bader, J.S., Zhan, J.et al (2014). Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat. Commun. 5, 5748.
51. Haas, H.L., Sergeeva, O.A.and Selbach, O. (2008). Histamine in the nervous system. Physiol Rev. 88, 1183- 1241.
52. Hagedorn, M., Carter, V.L., Leong, J.C.and Kleinhans, F.W. (2010). Physiology and cryosensitivity of coral endosymbiotic algae (Symbiodinium). Cryobiology 60, 147-158.
53. Hamdani, N., Doukhan, R., Kurtlucan, O., Tamouza, R.and Leboyer, M. (2013). Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications. Curr. Psychiatry Rep. 15, 387.
54. Hanrahan, J.R., Chebib, M.and Johnston, G.A. (2011). Flavonoid modulation of GABA(A) receptors. Br J Pharmacol 163, 234-245.
55. Harwood, M., nielewska-Nikiel, B., Borzelleca, J.F., Flamm, G.W., Williams, G.M.and Lines, T.C. (2007). A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 45, 2179-2205.
56. Heneka, M.T., Carson, M.J., Khoury, J.E., Landreth, G.E., Brosseron, F., Feinstein, D.L.et al (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14, 388-405.
57. Ho, L., Ferruzzi, M.G., Janle, E.M., Wang, J., Gong, B., Chen, T.Y.et al (2013). Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J 27, 769-781.
58. Hodes, G.E., Pfau, M.L., Leboeuf, M., Golden, S.A., Christoffel, D.J., Bregman, D.et al (2014). differences in the peripheral immune system promote resilience versus susceptibility Proc. Natl. Acad. Sci. U.S.A 111, 16136-16141.
59. Hollman, P.C., de Vries, J.H., van Leeuwen, S.D., Mengelers, M.J.and Katan, M.B. (1995). dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am.J Clin. 1282.
60. Hollman, P.C., Katan, M.B. (1997). Absorption, metabolism and health effects of dietary man. Biomed. Pharmacother. 51, 305-310.
61. Hsiao, E.Y., McBride, S.W., Chow, J., Mazmanian, S.K.and Patterson, P.H. (2012). Modeling factor in mice leads to permanent immune dysregulation. Proc. Natl. Acad. Sci. U.S.A 109,
62. Huang, M., Pang, X., Karalis, K.and Theoharides, T.C. (2003). Stress-induced interleukin- mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. Cardiovasc. 249.
63. Iantorno, M., Campia, U., Di, D.N., Nistico, S., Forleo, G.B., Cardillo, C.et al (2014). Obesity, and endothelial dysfunction. J Biol. Regul. Homeost. Agents 28, 169-176.
64. Jager, A.K., Saaby, L. (2011). Flavonoids and the CNS. Molecules. 16, 1471-1485.
65. Jang, S., Dilger, R.N.and Johnson, R.W. (2010). Luteolin inhibits microglia and alters hippocampal dependent spatial working memory in aged mice. J Nutr. 140, 1892-1898
66. Jang, S., Kelley, K.W.and Johnson, R.W. (2008). Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci USA 105, 7534-7539.
67. Jang, S.W., Liu, X., Yepes, M., Shepherd, K.R., Miller, G.W., Liu, Y.et al (2010). A selective TrkB agonist with potent neurotrophic activities by 7, 8-dihydroxyflavone. Proc Natl Acad Sci USA 107, 2687-2692.
68. Jones, K.A., Thomsen, C. (2013). The role of the innate immune system in psychiatric disorders. Mol. Cell Neurosci. 53, 52-62.
69. Jones, Q.R., Warford, J., Rupasinghe, H.P.and Robertson, G.S. (2012). Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci 33, 602-610.
70. Joulia, R., Gaudenzio, N., Rodrigues, M., Lopez, J., Blanchard, N., Valitutti, S.et al (2015). Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence. Nat. Commun. 6, 6174.
71. Kalesnikoff, J., Galli, S.J. (2008). New developments in mast cell biology. Nat. Immunol 9, 1215-1223.
72. Kalogeromitros, D., Makris, M., Chliva, C., Aggelides, X., Kempuraj, D.and Theoharides, T.C. (2008). A quercetin containing supplement reduces niacin-induced flush in humans. Int J Immunopathol Pharmacol. 21, 509-514.
73. Kalogeromitros, D., Syrigou, E.I., Makris, M., Kempuraj, D., Stavrianeas, N.G., Vasiadi, M.et al (2007). Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis. Annals Allergy, Asthma, Immunology 98, 269-273.
74. Kamei, C., Tasaka, K. (1993). Effect of histamine on memory retrieval in old rats. Biol. Pharm. Bull. 16, 128- 132.
75. Kandere-Grzybowska, K., Letourneau, R., Kempuraj, D., Donelan, J., Poplawski, S., Boucher, W.et al (2003). IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 171, 4830-4836.
76. Kao, T.K., Ou, Y.C., Lin, S.Y., Pan, H.C., Song, P.J., Raung, S.L.et al (2011). Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. J Nutr. Biochem. 22, 612-624.
77. Kawanishi, S., Oikawa, S.and Murata, M. (2005). Evaluation for safety of antioxidant chemopreventive agents. Antioxid. Redox. Signal. 7, 1728-1739.
78. Kawikova, I., Askenase, P.W. (2014). Diagnostic and therapeutic potentials of exosomes in CNS diseases. Brain Res.
79. Kempuraj, D., Madhappan, B., Christodoulou, S., Boucher, W., Cao, J., Papadopoulou, N.et al (2005). Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase theta phosphorylation in human mast cells. Br J Pharmacol 145, 934-944.
80. Kempuraj, D., Tagen, M., Iliopoulou, B.P., Clemons, A., Vasiadi, M., Boucher, W.et al (2008). Luteolin myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat cells. Br J Pharmacol 155, 1076-1084.
81. Kerr, D., Krishnan, C., Pucak, M.L.and Carmen, J. (2005). The immune system and neuropsychiatric diseases. Int. Rev. Psychiatry 17, 443-449.
82. Khemka, V.K., Bagchi, D., Bandyopadhyay, K., Bir, A., Chattopadhyay, M., Biswas, A.et al (2014). Altered serum levels of adipokines and insulin in probable Alzheimer's disease. J Alzheimers.Dis. 41, 525-533.
83. Kilburn, K.H. (2009). Neurobehavioral and pulmonary impairment in 105 adults with indoor exposure molds compared to 100 exposed to chemicals. Toxicol. Ind. Health 25, 681-692.
84. Kiliaan, A.J., Arnoldussen, I.A.and Gustafson, D.R. (2014). Adipokines: a link between obesity and dementia? Lancet Neurol. 13, 913-923.
85. Kimata, M., Shichijo, M., Miura, T., Serizawa, I., Inagaki, N.and Nagai, H. (2000). Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 30, 501-508.
86. Kovanen, P.T., Kaartinen, M.and Paavonen, T. (1995). Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92, 1084-1088.
87. Kritas, S.K., Caraffa, A., Antinolfi, P., Saggini, A., Pantalone, A., Rosati, M.et al (2014). Nerve growth factor interactions with mast cells. Int J Immunopathol Pharmacol 27, 15-19.
88. Kritas, S.K., Saggini, A., Cerulli, G., Caraffa, A., Antinolfi, P., Pantalone, A.et al (2014). Corticotropin-releasing hormone, microglia and mental disorders. Int. J Immunopathol. Pharmacol 27, 163-167.
89. Laine, P., Kaartinen, M., Penttilä, A., Panula, P., Paavonen, T.and Kovanen, P.T. (1999). Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 99, 361-369.
90. Landete, J.M., De las, R.B., Marcobal, A.and Munoz, R. (2008). Updated molecular knowledge about histamine biosynthesis by bacteria. Crit Rev. Food Sci Nutr. 48, 697-714.
91. Larsen, F.O., Clementsen, P., Hansen, M., Maltbaek, N., Gravesen, S., Skov, P.S.et al (1996). The indoor microfungus Trichoderma viride potentiates histamine release from human bronchoalveolar cells. APMIS 104, 673-679.
92. Lebwohl, B., Ludvigsson, J.F. (2014). Editorial: 'brain fog' and coeliac disease - evidence for its existence. Aliment. Pharmacol Ther 40, 565.
93. Li, W., Sperry, J.B., Crowe, A., Trojanowski, J.Q., Smith, A.B., IIIand Lee, V.M. (2009). Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau. J Neurochem. 110, 1339-1351.
94. Li, X., Chauhan, A., Sheikh, A.M., Patil, S., Chauhan, V., Li, X.M.et al (2009). Elevated immune response in the brain of autistic patients. J.Neuroimmunol. 207, 111-116.
95. Libby, P., Ridker, P.M.and Maseri, A. (2002). Inflammation and atherosclerosis. Circulation 105, 1135- 1143.
96. Lichtwark, I.T., Newnham, E.D., Robinson, S.R., Shepherd, S.J., Hosking, P., Gibson, P.R.et al (2014). Cognitive impairment in coeliac disease improves on a gluten-free diet and correlates with histological and serological indices of disease severity. Aliment. Pharmacol Ther 40, 160-170.
97. Lin, T.Y., Lu, C.W., Chang, C.C., Huang, S.K.and Wang, S.J. (2011). Luteolin inhibits the release of glutamate in rat cerebrocortical nerve terminals. J Agric. Food Chem. 59, 8458-8466.
98. Liu, R., Gao, M., Qiang, G.F., Zhang, T.T., Lan, X., Ying, J.et al (2009). The anti-amnesic effects of luteolin against amyloid beta(25-35) peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience 162, 1232-1243.
99. Liu, R., Zhang, T.T., Zhou, D., Bai, X.Y., Zhou, W.L., Huang, C.et al (2013). Quercetin protects against the Abeta(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU. Neuropharmacology 67, 419-431.
100. Liu, Y., Fu, X., Lan, N., Li, S., Zhang, J., Wang, S.et al (2014). Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav. Brain Res. 267, 178-188.
101. Lopez-Lazaro, M. (2009). Distribution and biological activities of the flavonoid luteolin. Mini. Rev Med Chem 9, 31-59.
102. Maintz, L., Novak, N. (2007). Histamine and histamine intolerance. Am. J Clin Nutr. 85, 1185-1196.
103. Martinez-Lapiscina, E.H., Clavero, P., Toledo, E., San, J.B., Sanchez-Tainta, A., Corella, D.et al (2013). Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr.Health Aging 17, 544-552.
104. Mathew, A., Yoshida, Y., Maekawa, T.and Kumar, D.S. (2011). Alzheimer's disease: cholesterol a menace? Brain Res.Bull. 86, 1-12.
105. Matusik, P., Guzik, B., Weber, C.and Guzik, T.J. (2012). Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thromb Haemost. 108, 443-456.
106. McKittrick, C.M., Lawrence, C.E.and Carswell, H.V. (2015). Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia. J Cereb. Blood Flow Metab 35, 638-647.
107. Mecocci, P., Tinarelli, C., Schulz, R.J.and Polidori, M.C. (2014). Nutraceuticals in cognitive impairment and Alzheimer's disease. Front Pharmacol. 5, 147.
108. Middleton, E.J., Kandaswami, C.and Theoharides, T.C. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 52, 673-751.
109. Miller, L.G., Lee-Parritz, A., Greenblatt, D.J.and Theoharides, T.C. (1988). High affinity benzodiazepine receptors on rat peritoneal mast cells and RBL-1 cells: binding characteristics and effects on granule secretion. Pharmacology 36, 52-60.
110. Mohagheghi, F., Bigdeli, M.R., Rasoulian, B., Hashemi, P.and Pour, M.R. (2011). The neuroprotective effect of olive leaf extract is related to improved blood-brain barrier permeability and brain edema in rat with experimental focal cerebral ischemia. Phytomedicine. 18, 170-175.
111. Mohagheghi, F., Bigdeli, M.R., Rasoulian, B., Zeinanloo, A.A.and Khoshbaten, A. (2010). Dietary virgin olive oil reduces blood brain barrier permeability, brain edema, and brain injury in rats subjected to ischemia3 reperfusion. ScientificWorldJournal. 10, 1180-1191.
112. Molyva, D., Kalokasidis, K., Poulios, C., Dedi, H., Karkavelas, G., Mirtsou, V.et al (2014). Rupatadine effectively prevents the histamine-induced up regulation of histamine H1R and bradykinin B2R receptor gene expression in the rat paw. Pharmacol Rep. 66, 952-955.
113. Moura, D.S., Georgin-Lavialle, S., Gaillard, R.and Hermine, O. (2014). Neuropsychological Features of Adult Mastocytosis. Immunol Allergy Clin North Am 34, 407-422.
114. Moura, D.S., Sultan, S., Georgin-Lavialle, S., Barete, S., Lortholary, O., Gaillard, R.et al (2012). Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression. PLoS.ONE. 7, e39468.
115. Moussion, C., Ortega, N.and Girard, J.P. (2008). The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS.ONE. 3, e3331.
116. Mullen, W., Gonzalez, J., Siwy, J., Franke, J., Sattar, N., Mullan, A.et al (2011). A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics. J Agric. Food Chem 59, 12850-12857.
117. Munkholm, K., Vinberg, M.and Vedel, K.L. (2013). Cytokines in bipolar disorder: a systematic review and meta-analysis. J Affect. Disord. 144, 16-27.
118. Nakae, S., Suto, H., Berry, G.J.and Galli, S.J. (2007). Mast cell-derived TNF can promote Th17 cell dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 109, 3640-3648.
119. Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J.D., Tsai, M.et al (2006). Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176, 2238-2248.
120. Nakao, A., Nakamura, Y.and Shibata, S. (2015). The circadian clock functions as a potent regulator of allergic reaction. Allergy 70, 467-473.
121. Nautiyal, K.M., Ribeiro, A.C., Pfaff, D.W.and Silver, R. (2008). Brain mast cells link the immune system to anxiety-like behavior. Proc Natl Acad Sci U S A 105, 18053-18057.
122. Ocon, A.J. (2013). Caught in the thickness of brain fog: exploring the cognitive symptoms of Chronic Fatigue Syndrome. Front Physiol 4, 63.
123. Orsetti, M., Ghi, P.and Di, C.G. (2001). Histamine H(3)-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two-trial place recognition task. Behav. Brain Res. 124, 235-242.
124. Pang, X., Letourneau, R., Rozniecki, J.J., Wang, L.and Theoharides, T.C. (1996). Definitive characterization of rat hypothalamic mast cells. Neuroscience 73, 889-902.
125. Papaliodis, D., Boucher, W., Kempuraj, D.and Theroharides, T.C. (2008). The flavonoid luteolin inhibits niacin-induced flush. Brit J Pharmacol 153, 1382-1387.
126. Pardo, C.A., Vargas, D.L.and Zimmerman, A.W. (2005). Immunity, neuroglia and neuroinflammation in autism. Int. Rev. Psychiatry 17, 485-495.
127. Parker-Athill, E., Luo, D., Bailey, A., Giunta, B., Tian, J., Shytle, R.D.et al (2009). Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism. J Neuroimmunol. 217, 20-27.
128. Passamonti, S., Terdoslavich, M., Franca, R., Vanzo, A., Tramer, F., Braidot, E.et al (2009). Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr. Drug Metab 10, 369-394.
129. Perez-Vizcaino, F., Duarte, J. (2010b). Flavonols and cardiovascular disease. Mol.Aspects Med 31, 478- 494.
130. Perez-Vizcaino, F., Duarte, J. (2010a). Flavonols and cardiovascular disease. Mol.Aspects Med 31, 478-494.
131. Peterson, J.J., Dwyer, J.T., Jacques, P.F.and McCullough, M.L. (2012). Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr. Rev 70, 491-508.
132. Petra AI, Panagiotidou S, Stewart JM, Conti Pand Theoharides TC (2014). Spectrum of mast cell activation disorders. Expert.Rev Clin Immunol 10, 729-739.
133. Pitt, J., Roth, W., Lacor, P., Smith, A.B., III, Blankenship, M., Velasco, P.et al (2009). Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol. Appl. Pharmacol. 240, 189-197.
134. Pizza, V., Agresta, A., D'Acunto, C.W., Festa, M.and Capasso, A. (2011). Neuroinflamm-aging and neurodegenerative diseases: an overview. CNS.Neurol Disord Drug Targets. 10, 621-634.
135. Prester, L. (2011). Biogenic amines in fish, fish products and shellfish: a review. Food Addit. Contam Part A Chem. Anal. Control Expo. Risk Assess. 28, 1547-1560.
136. Qiao, H., Andrade, M.V., Lisboa, F.A., Morgan, K.and Beaven, M.A. (2006). FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107, 610-618.
137. Raffa, R.B. (2011). A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog'). J Clin Pharm.Ther 36, 257-259.
138. Rea, W.J., Didriksen, N., Simon, T.R., Pan, Y., Fenyves, E.J.and Griffiths, B. (2003). Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Arch. Environ. Health 58, 399-405.
139. Regitz, C., Dussling, L.M.and Wenzel, U. (2014). Amyloid-beta (Abeta(1-42))-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways. Mol.Nutr.Food Res. 58, 1931-1940.
140. Reinhard, M.J., Satz, P., Scaglione, C.A., D'Elia, L.F., Rassovsky, Y., Arita, A.A.et al (2007). Neuropsychological exploration of alleged mold neurotoxicity. Arch. Clin Neuropsychol. 22, 533-543.
141. Rizk, A., Curley, J., Robertson, J.and Raber, J. (2004). Anxiety and cognition in histamine H3 receptor-/- mice. Eur.J Neurosci. 19, 1992-1996.
142. Ross, A.J., Medow, M.S., Rowe, P.C.and Stewart, J.M. (2013). What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin Auton.Res. 23, 305-311.
143. Rossignol, D.A., Frye, R.E. (2012). A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol.Psychiatry 17, 389-401.
144. Rozniecki, J.J., Dimitriadou, V., Lambracht-Hall, M., Pang, X.and Theoharides, T.C. (1999). Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo. Brain Res 849, 1-15.
145. Rozniecki, J.J., Letourneau, R., Sugiultzoglu, M., Spanos, C., Gorbach, J.and Theoharides, T.C. (1999). Differential effect of histamine-3 receptor active agents on brain, but not peritoneal, mast cell activation. J Pharmacol Exp Ther 290, 1427-1435.
146. Sakata, Y., Komamura, K., Hirayama, A., Nanto, S., Kitakaze, M., Hori, M.et al (1996). Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina. Am. J. Cardiol. 77, 1121-1126.
147. Sandoval-Cruz, M., Garcia-Carrasco, M., Sanchez-Porras, R., Mendoza-Pinto, C., Jimenez-Hernandez, M., Munguia-Realpozo, P.et al (2011). Immunopathogenesis of vitiligo. Autoimmun. Rev. 10, 762-765.
148. Schmidt, B.M., Ribnicky, D.M., Lipsky, P.E.and Raskin, I. (2007). Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 3, 360-366.
149. Schwelberger, H.G. (2010). Histamine intolerance: a metabolic disease? Inflamm.Res. 59 Suppl 2, S219- S221.
150. Seelinger, G., Merfort, I.and Schempp, C.M. (2008). Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 74, 1667-1677.
151. Severance, E.G., Alaedini, A., Yang, S., Halling, M., Gressitt, K.L., Stallings, C.R.et al (2012). Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr.Res. 138, 48-53.
152. Shan, L., Bao, A.M.and Swaab, D.F. (2015). The human histaminergic system in neuropsychiatric disorders. Trends Neurosci. 38, 167-177.
153. Shefler, I., Salamon, P., Hershko, A.Y.and Mekori, Y.A. (2011). Mast cells as sources and targets of membrane vesicles. Curr. Pharm. Des 17, 3797-3804.
154. Sheikh, I.A., Ali, R., Dar, T.A.and Kamal, M.A. (2012). An overview on potential neuroprotective compounds for management of Alzheimer's disease. CNS.Neurol. Disord. Drug Targets. 11, 1006-1011.
155. Shenassa, E.D., Daskalakis, C., Liebhaber, A., Braubach, M.and Brown, M. (2007). Dampness and mold in the home and depression: an examination of mold-related illness and perceived control of one's home as possible depression pathways. Am. J Public Health 97, 1893-1899.
156. Shim, S.Y., Park, J.R.and Byun, D.S. (2012). 6-Methoxyluteolin from Chrysanthemum zawadskii var. latilobum suppresses histamine release and calcium influx via down-regulation of FcepsilonRI alpha chain expression. J Microbiol.Biotechnol. 22, 622-627.
157. Shoemaker, R.C., House, D.E. (2006). Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Neurotoxicol. Teratol. 28, 573-588.
158. Sismanopoulos, N., Delivanis, D.A., Alysandratos, K.D., Angelidou, A., Therianou, A., Kalogeromitros, D.et al (2012). Mast cells in allergic and inflammatory diseases. Curr.Pharm.Des 18, 2261-2277.
159. Sismanopoulos, N., Delivanis, D.A., Mavrommati, D., Hatziagelaki, E., Conti, P.and Theoharides, T.C. (2013). Do mast cells link obesity and asthma? Allergy 68, 8-15.
160. Skaper, S.D., Facci, L.and Giusti, P. (2013). Mast cells, glia and neuroinflammation: partners in crime? Immunology 141, 314-327.
161. Skaper, S.D., Giusti, P.and Facci, L. (2012). Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J 26, 3103-3117.
162. Skokos, D., Goubran-Botros, H., Roa, M.and Mecheri, S. (2002). Immunoregulatory properties of mast cell derived exosomes. Mol. Immunol 38, 1359-1362.
163. Smith, J.H., Butterfield, J.H., Pardanani, A., DeLuca, G.C.and Cutrer, F.M. (2011). Neurologic symptoms and diagnosis in adults with mast cell disease. Clin Neurol Neurosurg. 113, 570-574.
164. Smith, S.E., Li, J., Garbett, K., Mirnics, K.and Patterson, P.H. (2007). Maternal immune activation alters fetal brain development through interleukin-6. J.Neurosci. 27, 10695-10702.
165. Solanki, I., Parihar, P., Mansuri, M.L.and Parihar, M.S. (2015). Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv.Nutr. 6, 64-72.
166. Spinas, E., Kritas, S.K., Saggini, A., Mobili, A., Caraffa, A., Antinolfi, P.et al (2014). Role of mast cells in atherosclerosis: a classical inflammatory disease. Int. J Immunopathol. Pharmacol 27, 517-521.
167. Sumpter, T.L., Ho, C.H., Pleet, A.R., Tkacheva, O.A., Shufesky, W.J., Rojas-Canales, D.M.et al (2015). Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses. J Allergy Clin Immunol 135, 1019-1030.
168. Sun, Y., Li, D.G., Li, Q., Huang, L., He, Z., Zhang, F.et al (2015). Relationship between adipoq gene polymorphism and lipid levels and diabetes. J Biol.Regul.Homeost.Agents 29, 221-227.
169. Taliou, A., Zintzaras, E., Lykouras, L.and Francis, K. (2013). An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders. Clin Ther 35, 592-602.
170. Tan, Z.S., Seshadri, S. (2010). Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander? Alzheimers.Res.Ther 2, 6.
171. Theoharides TC., Petra AI, Taracanova A, Panagiotidou S, and Conti P. Targeting IL-33 in autoimmunity and inflammation. JPET in press. 2015.
172. Theoharides, T.C. (1990). Mast cells: the immune gate to the brain. Life Sci 46, 607-617.
173. Theoharides, T.C. (2009). Autism spectrum disorders and mastocytosis. Int J Immunopathol Pharmacol 22, 859-865.
174. Theoharides, T.C. (2013a). Atopic conditions in search of pathogenesis and therapy. Clin Ther 35, 544- 547.
175. Theoharides, T.C. (2013b). Is a subtype of autism "allergy of the brain"? Clin. Ther. 35, 584-591.
176. Theoharides, T.C. (2015). Mast cells promote malaria infection? Clin Ther in press.
177. Theoharides, T.C., Alysandratos, K.D., Angelidou, A., Delivanis, D.A., Sismanopoulos, N., Zhang, B.et al (2010). Mast cells and inflammation. Biochim Biophys Acta 1822 21-33
178. Theoharides, T.C., Angelidou, A., Alysandratos, K.D., Zhang, B., Asadi, S., Francis, K.et al (2012). Mast cell activation and autism. Biochim. Biophys. Acta 1822, 34-41.
179. Theoharides, T.C., Asadi, S. (2012). Unwanted interactions among psychotropic drugs and other treatments for Autism Spectrum Disorders. J Clin. Psychopharmacol. 32, 437-440.
180. Theoharides, T.C., Asadi, S.and Panagiotidou, S. (2012). A case series of a luteolin formulation (NeuroProtek(R)) in children with autism spectrum disorders. Int J Immunopathol Pharmacol 25, 317-323.
181. Theoharides, T.C., Asadi, S.and Patel, A. (2013). Focal brain inflammation and autism. J Neuroinflammation 10, 46.
182. Theoharides, T.C., Bondy, P.K., Tsakalos, N.D.and Askenase, P.W. (1982). Differential release of serotonin and histamine from mast cells. Nature 297, 229-231.
183. Theoharides, T.C., Cochrane, D.E. (2004b). Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 146, 1-12.
184. Theoharides, T.C., Cochrane, D.E. (2004a). Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol. 146, 1-12.
185. Theoharides, T.C., Conti, P.and Economu, M. (2014). Brain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolin. J Clin Psychopharmacol 34, 187-189.
186. Theoharides, T.C., Donelan, J.M., Papadopoulou, N., Cao, J., Kempuraj, D.and Conti, P. (2004). Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. 25, 563-568.
187. Theoharides, T.C., Douglas, W.W. (1978). Secretion in mast cells induced by calcium entrapped within phospholipid vesicles. Science 201, 1143-1145.
188. Theoharides, T.C., Doyle, R., Francis, K., Conti, P.and Kalogeromitros, D. (2008). Novel therapeutic targets for autism. Trends Pharmacol Sci. 29, 375-382.
189. Theoharides, T.C., Kempuraj, D., Tagen, M., Conti, P.and Kalogeromitros, D. (2007). Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 217, 65-78.
190. Theoharides, T.C., Konstantinidou, A. (2007). Corticotropin-releasing hormone and the blood-brain barrier. Front Biosci 12, 1615-1628.
191. Theoharides, T.C., Sismanopoulos, N., Delivanis, D.A., Zhang, B., Hatziagelaki, E.E.and Kalogeromitros, D. (2011a). Mast cells squeeze the heart and stretch the gird: Their role in atherosclerosis and obesity. Trends Pharmacol. Sci. 32, 534-542.
192. Theoharides, T.C., Spanos, C.P., Pang, X., Alferes, L., Ligris, K., Letourneau, R.et al ( 1995). Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology 136, 5745-5750.
193. Theoharides, T.C., Stewart, J.M., Panagiotidou, S.and Melamed, I. (2015). Mast cells, brain inflammation and autism. Eur J Pharmacol.
194. Theoharides, T.C., Valent, P.and Akin C. (2015). Mast cells, mastocytosis and related diseases. New Engl J Med in press.
195. Theoharides, T.C., Weinkauf, C.and Conti, P. (2004). Brain cytokines and neuropsychiatric disorders. J Clin Psychopharmacol 24, 577-581.
196. Theoharides, T.C., Zhang, B.and Conti, P. (2011b). Decreased mitochondrial function and increased brain inflammation in bipolar disorder and other neuropsychiatric diseases. J Clin Psychopharmacol. 31, 685- 687.
197. Theoharides, T.C., Zhang, B., Kempuraj, D., Tagen, M., Vasiadi, M., Angelidou, A.et al (2010). IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A 107, 4448-4453.
198. Thilakarathna, S.H., Rupasinghe, H.P. (2013). Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients. 5, 3367-3387.
199. Torrealba, F., Riveros, M.E., Contreras, M.and Valdes, J.L. (2012). Histamine and motivation. Front Syst.Neurosci. 6, 51.
200. Tsai, F.S., Peng, W.H., Wang, W.H., Wu, C.R., Hsieh, C.C., Lin, Y.T.et al (2007). Effects of luteolin on learning acquisition in rats: involvement of the central cholinergic system. Life Sci. 80, 1692-1698.
201. Tsilioni, I., Panagiotidou, S.and Theoharides, T.C. (2014). Exosomes in neurologic and psychiatric disorders. Clin. Ther. 36, 882-888.
202. United Nations, Department of Economic and Social Affairs Population Division, http:, and esa.un.org/wpp/documentation/WPP%202010%20publications.htm. World Population Prospects:The 2010 Revision. 2015.
203. Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J.H., Carter, M.C.et al (2012). Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 157, 215-225.
204. Vauzour, D. (2014). Effect of flavonoids on learning, memory and neurocognitive performance: relevance and potential implications for Alzheimer's disease pathophysiology. J Sci. Food Agric. 94, 1042-1056.
205. Verbeek, R., Plomp, A.C., van Tol, E.A.and van Noort, J.M. (2004). The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem. Pharmacol. 68, 621-629.
206. Walle, T. (2007). Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. Mol. Pharm 4, 826-832.
207. Wang, D.M., Li, S.Q., Wu, W.L., Zhu, X.Y., Wang, Y.and Yuan, H.Y. (2014). Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer's disease. Neurochem. Res. 39, 1533-1543.
208. Wei, G., Hwang, L.and Tsai, C. (2014). Absolute bioavailability, pharmacokinetics and excretion of 5, 7, 30, 40 -tetramethoxyflavone in rats. J Functional Foods 7, 136-141.
209. Weng Z, Patel A, Panagiotidou Sand Theoharides TC (2014). The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells. J Allergy Clin Immunol 14, 01574-01577.
210. Wilhelm, M., Silver, R.and Silverman, A.J. (2005). Central nervous system neurons acquire mast cell products via transgranulation. Eur. J Neurosci. 22, 2238-2248.
211. Xiong, Z., Thangavel, R., Kempuraj, D., Yang, E., Zaheer, S.and Zaheer, A. (2014). Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain. J Alzheimers. Dis. 40, 297- 308.
212. Xu, N., Zhang, L., Dong, J., Zhang, X., Chen, Y.G., Bao, B.et al (2014). Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice. Mol. Nutr. Food Res. 58, 1258-1268.
213. Xu, S.L., Bi, C.W., Choi, R.C., Zhu, K.Y., Miernisha, A., Dong, T.T.et al (2013). Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor. Evid. Based. Complement Alternat. Med. 2013, 127075.
214. Yang, C.J., Liu, C.L., Sang, B., Zhu, X.M.and Du, Y.J. (2015). The combined role of serotonin and interleukin-6 as biomarker for autism. Neuroscience 284, 290-296.
215. Yang, Y., Oh, J.M., Heo, P., Shin, J.Y., Kong, B., Shin, J.et al (2013). Polyphenols differentially inhibit degranulation of distinct subsets of vesicles in mast cells by specific interaction with granule-type dependent SNARE complexes. Biochem. J 450, 537-546.
216. Yap, S., Qin, C.and Woodman, O.L. (2010). Effects of resveratrol and flavonols on cardiovascular function: Physiological mechanisms. Biofactors 36, 350-359.
217. Yoo, D.Y., Choi, J.H., Kim, W., Nam, S.M., Jung, H.Y., Kim, J.H.et al (2013). Effects of luteolin on spatial memory, cell proliferation, and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia model. Neurol. Res. 35, 813-820.
218. Zhang, B., Alysandratos, K.D., Angelidou, A., Asadi, S., Sismanopoulos, N., Delivanis, D.A.et al (2011). Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis. J Allergy Clin Immunol 127, 1522-1531.
219. Zhang, B., Asadi, S., Weng, Z., Sismanopoulos, N.and Theoharides, T.C. (2012). Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PloS One 7, e49767.
220. Zhang, B., Weng, Z., Sismanopoulos, N., Asadi, S., Therianou, A., Alysandratos, K.D.et al (2012). Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells. Int Arch. Allergy Immunol 159, 23-32.
221. Zhu, L.H., Bi, W., Qi, R.B., Wang, H.D.and Lu, D.X. (2011). Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. Int J Neurosci. 121, 329-336.
222. Zhu, X., Perry, G., Smith, M.A.and Wang, X. (2012). Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's Disease. J Alzheimers. Dis. 33, S253-S262.
223. Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R.C.et al (2011). Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19, 1769-1779.
224. Zlomuzica, A., Viggiano, D., De Souza Silva, M.A., Ishizuka, T., Gironi Carnevale, U.A., Ruocco, L.A.et al (2008). The histamine H1-receptor mediates the motivational effects of novelty. Eur. J Neurosci. 27, 1461-1474.